PATENT CLAIM ANALYSIS

Application Number: 15920654
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["540", "594000"]

Abstract:
The invention generally relates to adenylyl cyclase inhibitor compounds and methods for treating neuropathic or inflammatory pain by using those compounds.

Claim (Index 30):
The method of claim  1 , wherein the adenylyl cyclase is adenylyl cyclase type I (AC1).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.04762
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15044660', '13141199', '11018019', '11733606', '12054083']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6347626482348336
- 35 USC 102 Novelty (BERT): 0.5378887107065923
- Combined Prediction Score: 0.6250752544820095
- Mean Citation Score: 216.056394
- Max Citation Score: 317.5019200000001
- Similarity Product: 187.01121930960664

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test